Contamination by opportunistic screening in the European Randomized Study of Prostate Cancer Screening
Open Access
- 1 December 2003
- journal article
- Published by Wiley in BJU International
- Vol. 92 (s2) , 97-100
- https://doi.org/10.1111/j.1464-410x.2003.04407.x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Effective PSA contamination in the Rotterdam section of the European Randomized Study of Screening for Prostate CancerInternational Journal of Cancer, 2003
- Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence TrendsJNCI Journal of the National Cancer Institute, 2002
- The accuracy of primary care patients’ self-reports of prostate-specific antigen testingAmerican Journal of Preventive Medicine, 2002
- Prostate cancer mortality reduction by screening: Power and time frame with complete enrollment in the European randomised screening for prostate cancer (ERSPC) trialInternational Journal of Cancer, 2001
- Large‐scale randomized prostate cancer screening trials: Program performances in the European randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trialInternational Journal of Cancer, 2001
- Survey of the rate of PSA testing in general practiceBritish Journal of Cancer, 2001
- Re: Prostate Cancer Incidence and Mortality in the United States and the United KingdomJNCI Journal of the National Cancer Institute, 2001
- Recommendations on cancer screening in the European UnionEuropean Journal Of Cancer, 2000
- Rationale for randomised trials of prostate cancer screeningEuropean Journal Of Cancer, 1999
- Latent Prostatic Cancer in a Consecutive Autopsy SeriesScandinavian Journal of Urology and Nephrology, 1980